Worsening QoL linked to early Tx discontinuation in breast c
For women with breast cancer, experiencing a worsening in menopause-specific quality of life (QoL) is associated with early treatment discontinuation, according to a study published online Jan. 9 in the Journal of Clinical Oncology.

Olivia Meggetto, from Queen's University in Kingston, Canada, and colleagues examined menopause-specific QoL among patients in the Mammary Prevention.3 (MAP.3) breast cancer prevention randomized, placebo-controlled trial evaluating exemestane. At entry and six months, 4,501 MAP.3 participants completed the Menopause-Specific Quality of Life Questionnaire (MENQOL).

Read more at: https://medicalxpress.com/news/2017-01-worsening-qol-linked-early-tx.html#jCp